Works matching IS 20953941 AND DT 2022 AND VI 19 AND IP 8
Results: 13
Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1274, doi. 10.20892/j.issn.2095-3941.2021.0108
- By:
- Publication type:
- Article
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1259, doi. 10.20892/j.issn.2095-3941.2022.0255
- By:
- Publication type:
- Article
Peripheral blood indices to predict PFS/OS with anlotinib as a subsequent treatment in advanced small-cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1249, doi. 10.20892/j.issn.2095-3941.2020.0727
- By:
- Publication type:
- Article
Lynch syndrome pre-screening and comprehensive characterization in a multi-center large cohort of Chinese patients with colorectal cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1235, doi. 10.20892/j.issn.2095-3941.2021.0585
- By:
- Publication type:
- Article
Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1225, doi. 10.20892/j.issn.2095-3941.2021.0642
- By:
- Publication type:
- Article
PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1211, doi. 10.20892/j.issn.2095-3941.2020.0294
- By:
- Publication type:
- Article
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1193, doi. 10.20892/j.issn.2095-3941.2020.0550
- By:
- Publication type:
- Article
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1173, doi. 10.20892/j.issn.2095-3941.2021.0130
- By:
- Publication type:
- Article
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibiting homologous recombination repair.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1150, doi. 10.20892/j.issn.2095-3941.2021.0178
- By:
- Publication type:
- Article
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1139, doi. 10.20892/j.issn.2095-3941.2020.0708
- By:
- Publication type:
- Article
Current cancer burden in China: epidemiology, etiology, and prevention.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1121, doi. 10.20892/j.issn.2095-3941.2022.0231
- By:
- Publication type:
- Article
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1117, doi. 10.20892/j.issn.2095-3941.2022.0403
- By:
- Publication type:
- Article
Epigenetic reprogramming in small cell lung cancer.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 8, p. 1111, doi. 10.20892/j.issn.2095-3941.2022.0343
- By:
- Publication type:
- Article